MiMedx Group, Inc.

MiMedx is a biopharmaceutical company developing, manufacturing and marketing biologics utilizing human placental-based allografts for multiple sectors of healthcare. “Treating more patients with better outcomes” is the framework behind our mission to elevate the standard of care in the communities we serve. We process human placental-based allografts using Purion®, a unique patented method that is in accordance with the American Association of Tissue Banks (AATB) standards. MiMedx placental-based allografts come from donated C-sections of live births in the US. The product undergoes active preservation of the extracellular matrix (ECM), regulatory proteins, and removal of blood contaminants via a proprietary cleansing process. For an additional level of safety, the product is terminally sterilized.